GWP.L Regulatory News (GWP)

26 Oct 2006 17:29

GW Pharmaceuticals PLC26 October 2006 BLOCKLISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: GW PHARMACEUTICALS PLC 2. NAME OF SCHEME: GW PHARMACEUTICALS APPROVED COMPANY SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 27 APRIL 2006 TO: 25 OCTOBER 2006 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUEDUNDER SCHEME AT END OF THE LAST PERIOD: 150,750 ORDINARY SHARES OF 0.1P EACH 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL ORDINARY SHARES OF 0.1P EACH 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 150,750 ORDINARY SHARES OF 0.1P EACH 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLYLISTED AND THE DATE OF ADMISSION: 507,146 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDERFOR US TO UPDATE OUR RECORDS. 120,076,035 ORDINARY SHARES OF 0.1P EACH BLOCKLISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: GW PHARMACEUTICALS PLC 2. NAME OF SCHEME: GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 27 APRIL 2006 TO: 25 OCTOBER 2006 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUEDUNDER SCHEME AT END OF THE LAST PERIOD: 604,962 ORDINARY SHARES OF 0.1P EACH 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL ORDINARY SHARES OF 0.1P EACH 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 604,962 ORDINARY SHARES OF 0.1P EACH 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLYLISTED AND THE DATE OF ADMISSION: 1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDERFOR US TO UPDATE OUR RECORDS. 120,076,035 ORDINARY SHARES OF 0.1P EACH BLOCKLISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: GW PHARMACEUTICALS PLC 2. NAME OF SCHEME: GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001 3. PERIOD OF RETURN: FROM: 27 APRIL 2006 TO: 25 OCTOBER 2006 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUEDUNDER SCHEME AT END OF THE LAST PERIOD: 435,358 ORDINARY SHARES OF 0.1P EACH 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL ORDINARY SHARES OF 0.1P EACH 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 435,358 ORDINARY SHARES OF 0.1P EACH 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLYLISTED AND THE DATE OF ADMISSION: 516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDERFOR US TO UPDATE OUR RECORDS. 120,076,035 ORDINARY SHARES OF 0.1P EACH BLOCKLISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: GW PHARMACEUTICALS PLC 2. NAME OF SCHEME: GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001 3. PERIOD OF RETURN: FROM: 27 APRIL 2006 TO: 25 OCTOBER 2006 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUEDUNDER SCHEME AT END OF THE LAST PERIOD: 1,276,492 ORDINARY SHARES OF 0.1P EACH 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL ORDINARY SHARES OF 0.1P EACH 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 1,276,492 ORDINARY SHARES OF 0.1P EACH 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLYLISTED AND THE DATE OF ADMISSION: 1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDERFOR US TO UPDATE OUR RECORDS. 120,076,035 ORDINARY SHARES OF 0.1P EACHFor further information, please contact: Jonathan Laughton, GW Pharmaceuticals plc Telephone: 01980 557000 This information is provided by RNS The company news service from the London Stock Exchange